SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-21-011657
Filing Date
2021-04-05
Accepted
2021-04-05 17:26:43
Documents
2
Group Members
CELGENE ALPINE INVESTMENT CO., LLCCELGENE CORPCELGENE EUROPEAN INVESTMENT CO LLCCELGENE SWITZERLAND LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A brhc10022784_sc13da.htm SC 13D/A 199463
2 JOINT FILING AGREEMENT brhc10022784_ex99-1.htm EX-99.1 14150
  Complete submission text file 0001140361-21-011657.txt   215518
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Subject) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87570 | Film No.: 21806759
SIC: 2834 Pharmaceutical Preparations